Search - tctmd.com

Displaying 1 - 20 of 1237

Sort: Relevancy | Date

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

News Conference News ACC 2026

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

April 01, 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

March 30, 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

Should Moderate FMR Should Be Treated With M-TEER? Experts Duke It Out

News Conference News THT 2026

Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out

March 06, 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

March 04, 2026

Presentation THT 2026

LAVA ECMO Support in Severe Mitral Regurgitation as a Bridge to Mitral Valve Repair

Presenter: Som Singh

March 04, 2026

Presentation THT 2026

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Presenter: Edwin Ho

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT Abstracts 2026

A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting

Presenter: Colin Barker

March 02, 2026

Presentation THT Abstracts 2026

Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study

Presenter: Philipp von Stein

March 02, 2026

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

THT 2026: What to Expect in Boston

News Conference News THT 2026

THT 2026: What to Expect in Boston

February 23, 2026

Meta-analysis Teases Out What Drives Success in M-TEER

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

February 10, 2026

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

December 31, 2025

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

Largest AI-Echo Model Shows Promise for Increasing Workflow Efficiency

News Daily News

Largest AI-Echo Model Shows Promise for Increasing Workflow Efficiency

Yael L. Maxwell

November 17, 2025

Presentation TCT 2025

CASE 4: Aortic Regurgitation and Mitral Regurgitation – Optimal Timing, Role of Surgery, and Staged Approaches

Presenter: Guido Ascione

October 28, 2025

Presentation TCT 2025

CASE 1 - Aortic Stenosis and Mitral Regurgitation – Many Shades of Gray

Presenter: Mahesh V. Madhavan

October 28, 2025

Presentation TCT 2025

Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation: Technology Update, Human Experience and Imaging Insights

Presenter: Susheel K. Kodali

October 28, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.